Eir’s first fund will partner Nordics-based universities to invest in their spinouts, while also making selected deals in the rest of Europe and the US.
Sweden-based venture capital firm Eir Ventures raised €76m ($86m) on Friday for the first close of a life sciences-oriented fund that will partner closely with universities across the Nordics and invest in their spinouts.
LPs for Eir’s inaugural fund include pharmaceutical firm Novo Holdings in addition to the EU-owned European Investment Fund, state-owned investment fund Danish Growth Fund (also known as Vækstfonden) and Swedish government-founded VC firm Saminvest.
Aside from its academic focus, Eir Ventures will work alongside…
